Literature DB >> 11425408

Crohn's disease: genetic susceptibility, bacteria, and innate immunity.

D A Van Heel1, D P McGovern, D P Jewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11425408     DOI： 10.1016/S0140-6736(00)05091-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease.

Authors:  Philippe Eloy; E Leruth; Y Goffart; M C Nollevaux; V Fridman; M Dartevelle; M Melange; J Daele; B Bertrand
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

2.  Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.

Authors:  D A van Heel; S Ghosh; K A Hunt; C G Mathew; A Forbes; D P Jewell; R J Playford
Journal:  Gut       Date:  2005-05-31       Impact factor: 23.059

3.  Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages.

Authors:  Bhagirath Chaurasia; Jan Mauer; Linda Koch; Julia Goldau; Anja-Sterner Kock; Jens C Brüning
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

Review 4.  Biologic therapy for inflammatory bowel disease.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease.

Authors:  Silvana Geleff; Sebastian F Schoppmann; Georg Oberhuber
Journal:  Virchows Arch       Date:  2003-01-16       Impact factor: 4.064

6.  Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Seiichi Kitagawa; Kenji Watanabe; Yasuhiro Fujiwara; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 7.  Autoimmune disorders: a concept of treatment based on mechanisms of disease.

Authors:  Peter A Miescher; Laura Zavota; Alejandra Ossandon; Bruno Lagana
Journal:  Springer Semin Immunopathol       Date:  2003-11-06

8.  Negative feedback circuit for toll like receptor-8 activation in human embryonic Kidney 293 using outer membrane vesicle delivered bi-specific siRNA.

Authors:  Anurag Adhikari; Birendra Prasad Gupta; Krishna Das Manandhar; Shravan Kumar Mishra; Hari Krishna Saiju; Rajendra Maan Shrestha; Nawneet Mishra; Shishir Sharma
Journal:  BMC Immunol       Date:  2015-07-23       Impact factor: 3.615

9.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13

10.  Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome.

Authors:  Bas B van Rijn; Arie Franx; Eric A P Steegers; Christianne J M de Groot; Rogier M Bertina; Gerard Pasterkamp; Hieronymus A M Voorbij; Hein W Bruinse; Mark Roest
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.